Compare CVS Health Corp (CVS) vs Nokia Corp (NOK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
CVS Health Corp vs Nokia Corp — how do they compare? CVS Health Corp trades at $93.7 (market cap $122.36B), while Nokia Corp trades at $9.51 (market cap $51.87B). The key difference: CVS Health Corp is far larger — about 2.4× Nokia Corp's market cap, and CVS Health Corp pays the higher dividend (2.78%). Which is the better fit depends on your goals.
| CVS | NOK | |
|---|---|---|
Market Cap | $122.36B | $51.87B |
Sector | Health | Technology |
52-Week High | $110.60 | $16.83 |
52-Week Low | $65.51 | $4.13 |
Enterprise Value | $184.71B | $49.82B |
Dividend Yield | 2.78% | 1.79% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
CVS Health trades at $95.70, down 0.54% on the day, with a bearish technical signal and key support at $95. The company reported strong Q2 2026 earnings, beating estimates with EPS of $2.58 versus $1.87 expected, and raised its full-year guidance. Revenue growth remains robust, reaching $402.07 billion in 2025, though net income margin compressed to 1.18%. Analyst sentiment is overwhelmingly positive with a consensus price target of $115.00.
The outlook for CVS is cautiously optimistic, driven by operational improvements in its Aetna segment and raised cash flow guidance. Investment opportunities include potential upside to the consensus target, but risks involve margin pressures, regulatory changes impacting pharmacy benefits in 2027, and high debt levels. The stock's current valuation at a P/E of 25.25 may limit near-term gains if earnings growth slows.
Nokia (NOK) trades at $9.37, down 0.53% on the day, with a bearish technical signal and neutral oscillators. The company reported mixed quarterly earnings, beating in Q2 2026 but missing in Q1, with Q3 results pending. Revenue for 2025 was $19.89B, with a net income margin of 3.47%. Analyst consensus is 60% buy, supported by strong cash flow from operations of $2.07B in 2025 and a focus on AI and cloud infrastructure growth.
Outlook is cautiously optimistic due to AI demand boosting earnings, but risks include telecom spending volatility and high P/E of 67.5. The stock offers growth potential from AI networking, yet investors face margin pressures and competitive threats in the telecom equipment sector.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About CVS Health Corp
Following its acquisition of Aetna in late 2018, CVS Health now provides an even more integrated healthcare-services offering for its members. Legacy CVS combined both the largest pharmacy benefit manager, processing over 2 billion adjusted claims annually, and a sizable pharmacy operation, including nearly 10,000 retail pharmacy locations primarily in the U.S. Adding a managed-care organization with 24 million medical members gives the company a strong position in the insurance industry and should help CVS better control overall healthcare costs for its clients.
Read more on CVS →About Nokia Corp
Nokia is a leading vendor in the telecommunications equipment industry. The company's network business derives revenue from selling wireless and fixed-line hardware, software, and services. Nokia's technology segment licenses its patent portfolio to handset manufacturers and makes royalties from Nokia-branded cellphones. The company, headquartered in Espoo, Finland, operates on a global scale, with most of its revenue from communication service providers.
Read more on NOK →
